본문 바로가기 주메뉴 바로가기
22대 대한민국 국회 국회정보길라잡이 국회의원검색
회원가입 로그인
HOME

정보검색

소장정보 검색

국회도서관 홈으로 정보검색 소장정보 검색
결과 내 검색 동의어 포함
결과 내 검색 동의어 포함

-

초록보기

Purpose A “Smart Cancer Care” platform that integrates patient-reported outcomes (PROs) with management has been established in Korea. This study focused on improving health behaviors and connecting patients to welfare services by introducing and assessing the feasibility of “Smart Cancer Care 2.0,” an enhanced version designed for monitoring complications post-cancer treatment.

Materials and Methods Smart Cancer Care 2.0 was developed by conducting a literature review and consulting with expert panels to identify symptoms or variables requiring monitoring and management guidelines based on the treatment type. Qualitative and quantitative surveys were conducted to assess the feasibility of the app and web system based on the experiences of patients with cancer and healthcare workers.

Results A total of 81 symptoms or variables (chemotherapy-, surgery-, radiotherapy-, rehabilitation-, and health management-related) were selected for management in Smart Cancer Care 2.0. PROs for these symptoms were basically categorized into three severity grades: preventive management, self-treatment, and consultation with a healthcare worker or visit to a healthcare institution. The overall mean scores in the feasibility evaluation by patients and healthcare workers were 3.83 and 3.90 points, respectively, indicating high usefulness.

Conclusion Smart Cancer Care 2.0 leverages the existing information and communication technologies–based platform, Smart Cancer Care, and further includes health behaviors and welfare services. Smart Cancer Care 2.0 may play a crucial role in establishing a comprehensive post-discharge management system for patients with cancer as it provides suitable interventions based on patients’ responses and allows the regularly collected PROs to be easily viewed for streamlined care.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
Recent advances in genomic approaches for the detection of homologous recombination deficiency Yoo-Na Kim, Doga C. Gulhan, Hu Jin, Dominik Glodzik, Peter J. Park p. 975-990
Precision oncology clinical trials : a systematic review of phase Ⅱ clinical trials with biomarker-driven, adaptive design Hyerim Ha, Hee Yeon Lee, Jee Hyun Kim, Do Yeun Kim, Ho Jung An, SeungJin Bae, Hye-sung Park, Jin Hyoung Kang p. 991-1013
Data resource profile : the cancer public library database in South Korea Dong-Woo Choi, Min Yeong Guk, Hye Ri Kim, Kwang Sun Ryu, Hyun-Joo Kong, Hyo Soung Cha, Hyun-Jin Kim, Heejung Chae, Young Sang Jeon, Hwanhee Kim, Jipmin Jung, Jeong-Soo Im, Kui Son Choi p. 1014-1026
Safe utilization and sharing of genomic data : amendment to the health and medical data utilization guidelines of South Korea Hyojeong Park, Jongkeun Park, Hyun Goo Woo, Hongseok Yun, Minho Lee, Dongwan Hong p. 1027-1039
Development and feasibility evaluation of smart cancer care 2.0 based on patient-reported outcomes for post-discharge management of patients with cancer Jin Ah Kwon, Songsoo Yang, Su-Jin Koh, Young Ju Noh, Dong Yoon Kang, Sol Bin Yang, Eun Ji Kwon, Jeong-Wook Seo, Jin Sung Kim, Minsu Ock p. 1040-1049
Therapeutic effect of anti-inflammatory tripeptide cream in hand-foot syndrome/skin reaction related to anticancer drugs : a randomized, double-blind, placebo-controlled pilot trial Yaewon Yang, Jang-Hee Hahn, Min Seo Kim, Minkwan Jo, Yong-Pyo Lee, Hongsik Kim, Hee Kyung Kim, Jihyun Kwon, Ki Hyeong Lee, Hye Sook Han p. 1050-1057
Metronomic S1 adjuvant chemotherapy improves survival in patients with locoregionally advanced nasopharyngeal carcinoma Yi-Feng Yu, Peng Wu, Rui Zhuo, San-Gang Wu p. 1058-1067
Analysis of response and progression patterns of tyrosine kinase inhibitors in recurrent or metastatic adenoid cystic carcinoma : a post hoc analysis of two KCSG phase Ⅱ trials Youjin Kim, Bhumsuk Keam, Eun Joo Kang, Jin-Soo Kim, Hye Ryun Kim, Keun-Wook Lee, Jung Hye Kwon, Kyoung Eun Lee, Yaewon Yang, Yoon Hee Choi ... [et al.] p. 1068-1076
(The) impact of infectious mononucleosis history on the risk of developing lymphoma and nasopharyngeal carcinoma : a retrospective large-scale cohort study using national health insurance data in South Korea So Hee Kang, Yun-Hee Lee, Jun-Pyo Myong, Minsu Kwon p. 1077-1083
Adjuvant pembrolizumab in patients with stage ⅢA/N2 non-small cell lung cancer completely resected after neoadjuvant concurrent chemoradiation : a prospective, open-label, single-arm, phase 2 trial Junghoon Shin, Sehhoon Park, Kyung Hwan Kim, Eui-Cheol Shin, Hyun Ae Jung, Jong Ho Cho, Jong-Mu Sun, Se-Hoon Lee, Yong Soo Choi, Jin Seok Ahn ... [et al.] p. 1084-1095
(A) nationwide study on HER2-low breast cancer in South Korea : its incidence of 2022 real world data and the importance of immunohistochemical staining protocols Min Chong Kim, Eun Yoon Cho, So Yeon Park, Hee Jin Lee, Ji Shin Lee, Jee Yeon Kim, Ho-chang Lee, Jin Ye Yoo, Hee Sung Kim, Bomi Kim ... [et al.] p. 1096-1104
Dural metastasis in breast cancer : MRI-based morphological subtypes and their clinical implications Sung Jun Ahn, Bio Joo, Mina Park, Hun Ho Park, Sang Hyun Suh, Sung Gwe Ahn, Jihwan Yoo p. 1105-1112
(A) 10-gene signature to predict the prognosis of early-stage triple-negative breast cancer Chang Min Kim, Kyong Hwa Park, Yun Suk Yu, Ju Won Kim, Jin Young Park, Kyunghee Park, Jong-Han Yu, Jeong Eon Lee, Sung Hoon Sim, Bo Kyoung Seo, Jin Kyeoung Kim, Eun Sook Lee, Yeon Hee Park, Sun-Young Kong p. 1113-1125
Identification of new pathogenic variants of hereditary diffuse gastric cancer Seung-Young Oh, Giyong Jang, Jaeryuk Kim, Kyoung-Yun Jeong, Hyun Myong Kim, Yoon Jin Kwak, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Sung-Yup Cho, Jong-Il Kim, Han-Kwang Yang p. 1126-1135
Varlitinib and paclitaxel for EGFR/HER2 co-expressing advanced gastric cancer : a multicenter phase Ib/Ⅱ study (K-MASTER-13) Dong-Hoe Koo, Minkyu Jung, Yeul Hong Kim, Hei-Cheul Jeung, Dae Young Zang, Woo Kyun Bae, Hyunki Kim, Hyo Song Kim, Choong-kun Lee, Woo Sun Kwon, Hyun Cheol Chung, Sun Young Rha p. 1136-1145
Effector function characteristics of exhausted CD8+ T-cell in microsatellite stable and unstable gastric cancer Dong-Seok Han, Yoonjin Kwak, Seungho Lee, Soo Kyung Nam, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Nak-Jung Kwon, Hye Seung Lee, Han-Kwang Yang p. 1146-1163
Association between endoscopist volume and interval cancers after colonoscopy : results from the national colorectal cancer screening program in Korea Dong Jun Kim, Nan-He Yoon, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seongju Kim, Ji Eun Kim, Hooyeon Lee p. 1164-1170
Longitudinal comparative analysis of circulating tumor DNA and matched tumor tissue DNA in patients with metastatic colorectal cancer receiving palliative first-line systemic anti-cancer therapy Seung-been Lee, Ji-Won Kim, Hong-Geun Kim, Sung-Hyun Hwang, Kui-Jin Kim, Ju Hyun Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Koung Jin Suh ... [et al.] p. 1171-1182
Evaluation of molecular residual disease by a fixed panel in resectable colorectal cancer Jian Yang, Chengqing Yu, Haoran Li, Di Peng, Qiaoxia Zhou, Jun Yao, Juan Lv, Shuai Fang, Jiaochun Shi, Yijun Wei, Guoqiang Wang, Shangli Cai, Zhihong Zhang, Zixiang Zhang, Jian Zhou p. 1183-1196
Prognostic significance of bulky nodal disease in anal cancer management : a multi institutional study Seok-Joo Chun, Eunji Kim, Won Il Jang, Mi-Sook Kim, Hyun-Cheol Kang, Byoung Hyuck Kim, Eui Kyu Chie p. 1197-1206
Efficacy of lenvatinib combined with anti-PD-1 antibodies plus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus : a retrospective, multicenter study Xiangye Ou, Junyi Wu, Jiayi Wu, Yangkai Fu, Zhenxin Zeng, Shuqun Li, Yinan Li, Deyi Liu, Han Li, Bin Li ... [et al.] p. 1207-1218
Clinical and radiologic predictors of response to atezolizumab-bevacizumab in advanced hepatocellular carcinoma Se Jin Choi, Sung Won Chung, Jonggi Choi, Kang Mo Kim, Hyung-Don Kim, Changhoon Yoo, Baek-Yeol Ryoo, Seung Soo Lee, Won-Mook Choi, Sang Hyun Choi p. 1219-1230
Distinct characteristics and changes in liver function of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab for more than 1 year Youngun Kim, Jung Sun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Yun Beom Sang, Sanghoon Jung, Chansik An, Chan Kim, Hong Jae Chon p. 1231-1239
Clinical outcomes of surgery after neoadjuvant chemotherapy in locally advanced pancreatic ductal adenocarcinoma Yoo Na Lee, Min Kyu Sung, Dae Wook Hwang, Yejong Park, Bong Jun Kwak, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Changhoon Yoo, Kyu-Pyo Kim, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim p. 1240-1251
Stratified treatment in pediatric anaplastic large cell lymphoma : result of a prospective open-label multiple-institution study Tingting Chen, Chenggong Zeng, Juan Wang, Feifei Sun, Junting Huang, Jia Zhu, Suying Lu, Ning Liao, Xiaohong Zhang, Zaisheng Chen ... [et al.] p. 1252-1261
Long term psychiatric and endocrine complications following hematopoietic stem cell transplantation in hematologic disease in Korea : a nation-wide cohort study Min Ji Jeon, Eunjin Noh, Seok Joo Moon, Eun Sang Yu, Chul Won Choi, Dae Sik Kim, Eun Joo Kang p. 1262-1269
Combination of dabrafenib and trametinib in patients with metastatic BRAF V600E-mutated thyroid cancer Youngkyung Jeon, Sehhoon Park, Se-Hoon Lee, Tae Hyuk Kim, Sun Wook Kim, Myung-Ju Ahn, Hyun Ae Jung, Jae Hoon Chung p. 1270-1276
Development of a prediction model for delirium in hospitalized patients with advanced cancer Eun Hee Jung, Shin Hye Yoo, Si Won Lee, Beodeul Kang, Yu Jung Kim p. 1277-1287

추천서가 (다양한 추천 자료를 만나보세요)

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차